President Trump's threat of imposing hefty tariffs on imported pharmaceuticals could significantly impact the US drug market. While aiming to lower drug costs, these tariffs risk increasing prices, disrupting supply chains, and potentially causing shortages, especially for generic drugs. Experts warn of inflationary effects, particularly impacting lower-income households and the elderly. Although some drugmakers are investing in US production, building new facilities is expensive and time-consuming, and tariffs might still affect imported ingredients. The potential impact on generic drug availability is a major concern, given their significant share of the US market.

Prepared by Christopher Adams and reviewed by editorial team.